Connect with us

Company News

CeriBell closes upsized IPO

CeriBell, Inc. announced the closing of its upsized initial public offering of 12,196,969 shares of its common stock at a public offering price of $17.00 per share, which includes 1,590,909 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares. The total gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Ceribell, were approximately $207.3 million. All of the shares of common stock were offered by Ceribell. Ceribell’s common stock began trading on the Nasdaq Global Select Market on October 11, 2024 under the ticker symbol “CBLL”.

BofA Securities and J.P. Morgan acted as joint book-running managers and as representatives of the underwriters for the offering. William Blair, TD Cowen and Canaccord Genuity acted as co-managers for the offering.

A registration statement relating to the shares sold in this offering was filed with the Securities and Exchange Commission and became effective on October 10, 2024.
MB Bureau

Copyright © 2026 Medical Buyer maintained by Algocept

error: Content is protected !!